Mats Åkerlund (Former)
1 – 24 of 24
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Myometrial oxytocin receptor mRNA concentrations at preterm and term delivery-the influence of external oxytocin
(
- Contribution to journal › Article
- 2008
-
Mark
Endometrial expression of vasopressin, oxytocin and their receptors in patients with primary dysmenorrhoea and healthy volunteers at ovulation.
(
- Contribution to journal › Article
-
Mark
Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects.
(
- Contribution to journal › Article
- 2006
-
Mark
Decreased serum level of macrophage inflammatory chemokine-3 beta/CCL19 in preterm labor and delivery
(
- Contribution to journal › Article
-
Mark
Targeting the oxytocin receptor to relax the myometrium.
(
- Contribution to journal › Scientific review
-
Mark
Validation of a test model of induced dysmenorrhea.
(
- Contribution to journal › Article
-
Mark
Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhea.
(
- Contribution to journal › Article
- 2005
-
Mark
The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor.
(
- Contribution to journal › Article
-
Mark
Recording of biosignals from the human uterus, a basis for the development of new therapies in preterm labour and primary dysmenorrhoea.
2005) Euroregional Conference on Building Information Society in the Healthcare in Euroregion Niemen 50(Suppl. 2). p.7-8(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2004
-
Mark
Vasopressin and oxytocin in normal reproduction and in the patophysiology of preterm labour and primary dysmenorrhoea. Development of receptor antagonists for therapeutic use in these conditions.
(
- Contribution to journal › Article
-
Mark
Preterm labour and delivery - therapy: the future
2004)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Anti-oxytocies as tocolytics
2004)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women
(
- Contribution to journal › Article
-
Mark
Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women.
(
- Contribution to journal › Article
-
Mark
Antioxitócicos como tocoliticosis
2004) p.167-167(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Oxytocin mRNA content in the endometrium of non-pregnant women.
(
- Contribution to journal › Article
-
Mark
ONO-8815Ly, an EP2 agonist that markedly inhibits uterine contractions in women.
(
- Contribution to journal › Article
- 2003
-
Mark
FE 200 440: a selective oxytocin antagonist on the term-pregnant human uterus.
(
- Contribution to journal › Article
- 2002
-
Mark
Oxytocin antagonists in the treatment of preterm labour.
(
- Contribution to journal › Article
-
Mark
Menstruationssmärta - ett nödvändigt ont
2002) p.5-5(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea.
(
- Contribution to journal › Scientific review
-
Mark
Kan menstruationssmärtor och för tidig födelse förhindras?
2002) p.25-25(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2001
-
Mark
Contractility of the myometrium; the rationale for pharmacological intervention in preterm labour
(
- Contribution to journal › Letter
- 1976
-
Mark
Studies on myometrial activity and endometrial blood flow in the non-pregnant human uterus
1976)(
- Thesis › Doctoral thesis (compilation)